Co-expression of Skp and FkpA chaperones improves cell viability and alters the global expression of stress response genes during scFvD1.3 production
Open Access
- 1 January 2010
- journal article
- Published by Springer Nature in Microbial Cell Factories
- Vol. 9 (1) , 22
Abstract
The overexpression of scFv antibody fragments in the periplasmic space of Escherichia coli frequently results in extensive protein misfolding and loss of cell viability. Although protein folding factors such as Skp and FkpA are often exploited to restore the solubility and functionality of recombinant protein products, their exact impact on cellular metabolism during periplasmic antibody fragment expression is not clearly understood. In this study, we expressed the scFvD1.3 antibody fragment in E. coli BL21 and evaluated the overall physiological and global gene expression changes upon Skp or FkpA co-expression.Keywords
This publication has 69 references indexed in Scilit:
- Development of antibody fragments for immunotherapy of prion diseasesBiochemical Journal, 2009
- Use of folding modulators to improve heterologous protein production in Escherichia coliMicrobial Cell Factories, 2009
- Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overviewMicrobial Cell Factories, 2008
- Prokaryotic expression of antibodiesCancer and Metastasis Reviews, 2005
- Engineered antibody fragments and the rise of single domainsNature Biotechnology, 2005
- Recombinant protein folding and misfolding in Escherichia coliNature Biotechnology, 2004
- Crystal Structure of Skp, a Prefoldin-like Chaperone that Protects Soluble and Membrane Proteins from AggregationMolecular Cell, 2004
- Folding and Insertion of the Outer Membrane Protein OmpA Is Assisted by the Chaperone Skp and by LipopolysaccharideJournal of Biological Chemistry, 2003
- Recombinant antibody constructs in cancer therapyCurrent Opinion in Immunology, 1999
- Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis1999